biolase.com - נכסים נקיים למניה בודדת BIOL

BIOLASE, Inc. (BIOL) generates revenue through the sale of high-tech lasers for dental surgery. The BVPS trend reflects changes in net equity, with -0.11 becoming the new value for this metric. Expansion accelerated via partnerships with medical associations; however, the company is currently finalizing asset liquidation following bankruptcy, which precludes the possibility of independent development.

The book value per share reflects the net equity of BIOLASE, Inc. (BIOL) minus all liabilities, determining the intrinsic value of the business for the shareholder. By analyzing the book value per share, an investor sees the company's actual asset base, which for this laser systems ecosystem is maintained through the ownership of proprietary equipment and the creation of a high barrier to entry for competitors.